文章摘要
汪居安,王居义,蔡叶,等.基于网络药理学和分子对接技术探讨十九畏药对“郁金 -丁香”抗肝纤维化作用机制[J].安徽医药,2023,27(6):1083-1087.
基于网络药理学和分子对接技术探讨十九畏药对“郁金 -丁香”抗肝纤维化作用机制
Mechanism of Radix Curcumae-Flos Caryophylli moutan couple on anti-liver fibrosis based on network pharmacology and molecular docking
  
DOI:10.3969/j.issn.1009-6469.2023.06.006
中文关键词: 肝纤维化  十九畏  郁金  丁香  网络药理学  分子对接  蛋白质相互作用图谱
英文关键词: Liver fibrosis  Incompatibility of the nineteen herbal drugs  Radix Curcumae  Flos Caryophylli  Network pharmacology  Molecular docking  Protein interaction mapping
基金项目:国家自然科学基金面上项目( 82170618);安徽省大学生创新创业训练计划( S201910368025)
作者单位E-mail
汪居安 中国科学技术大学附属第一医院肝胆外科安徽合肥 241002  
王居义 安徽中医药大学中医学院安徽合肥 230038  
蔡叶 中国科学技术大学附属第一医院肝胆外科安徽合肥 241002
皖南医学院临床医学院安徽芜湖 230001 
 
李幸蓉 中国科学技术大学附属第一医院肝胆外科安徽合肥 241002
皖南医学院临床医学院安徽芜湖 230001 
 
吴凌 中国科学技术大学附属第一医院肝胆外科安徽合肥 241002
安徽理工大学医学院安徽淮南 232001 
 
伊艳敏 中国科学技术大学附属第一医院肝胆外科安徽合肥 241002
安徽理工大学医学院安徽淮南 232001 
 
檀啸 皖南医学院临床医学院安徽芜湖 230001  
王继洲 中国科学技术大学附属第一医院肝胆外科安徽合肥 241002 wangjizhou1984@hotmail.com 
摘要点击次数: 666
全文下载次数: 426
中文摘要:
      目的通过网络药理学和分子对接技术探讨郁金 -丁香药对抗肝纤维化的作用机制。方法于 2022年 1月 8日检索中药系统药理学数据平台( TCMSP)获取郁金和丁香的有效活性成分及相关靶点并进行筛选和预测;肝纤维化相关靶点的数据通过 NCBI基因数据、 OMIM数据库和 Genecards数据库获取;运用软件 Venny 2.1绘制药物 -疾病靶点韦恩图,得到药物抗肝纤维化的作用靶点;运用 Cytoscape 3.8.2软件构建药物 -活性成分 -靶点相互作用网络并分析其拓扑结构;运用 String数据库构建蛋白质相互作用( PPI)网络图;利用 David和 Metascape数据库对关键靶点分别进行基因本体( GO)和京都基因与基因组百科全书( KEGG)富集分析;利用 PubChem和 RCSBPDB数据库对关键成分和靶点进行分子对接。结果筛选得到郁金 -丁香药活性成分 44个,对应作用靶点 200个,肝纤维化候选靶点 3 951个,药物与疾病交集靶点 155个。药物 -活性成分 -靶点网络和 PPI网络分析显示槲皮素、山柰酚、柚皮素、 β-谷甾醇等是药对治疗肝纤维化的关键成分,蛋白激酶 B1(AKT1)、白细胞介素(IL)-6、IL1β、牛胱天蛋白酶 3(CASP3)等为治疗的核心靶点。 155个潜在靶点经 GO富集至 1 889条生物学过程、 44条细胞组分表达和 94个分子功能相关的过程中。 KEGG通路分析显示与 133条通路有关,涉及癌症信号通路、乙型肝炎信号通路、 TNF信号通路、 Toll样受体信号通路等。分子对接表明关键成分与核心靶点结合良好。结论从网络药理学角度阐明了郁金 -丁香药多成分、多靶点、多途径的整体调节特点,初步揭示了其抗肝纤维化的作用机制,为后续研究提供思路与依据。
英文摘要:
      Objective To explore the mechanism of Radix Curcumae-Flos Caryophylli moutan couple against liver fibrosis (LF) by network pharmacology and molecular docking.Methods On January 8, 2022, the effective active ingredients and related targets of Ra? dix Curcumae-Flos Caryophylli moutan couple were screened and predicted by searching the TCMSP. Datebase of NCBI, OMIM andGenecards were used to obtain liver fibrosis-related targets. Venny 2.1 software was used to draw the drug-disease venn diagram and obtain the targets of moutan couple against LF. Cytoscape 3.8.2 software was utilized to build a drug-active ingredient-target interactionnetwork and to carry out topological analysis. String database was employed to establish PPI network. The GO and KEGG enrichmentwere carried out through the David and Metascape database. The molecular docking of drug active ingredient and target was based onPubChem and RCSBPDB database.Results A total of 44 active components with 200 corresponding targets, 3951 candidate targetsfor liver fibrosis and 155 common targets for drugs and disease were acquired. Through the analysis of disease-active component-target network and PPI network, quercetin, kaempferol, sitosterol were the key compounds and the core targets were AKT1, IL-6 IL-1β, CASP3, etc. GO entries included 1 889 biological process entries, 44 cellular component entries and 94 molecular function entries.There were 133 pathways involving cancer signaling pathway, TNF signaling pathway, Hepatitis B receptor signaling pathway, Toll-like receptor signaling pathway, etc. Molecular docking made clear that key compounds were well combined with core targets.Conclusion The results of this study verify the multi-component, multi-target and multi-pathway regulation characteristics of Radix Curcumae-Flos Caryophylli moutan couple, preliminarily predict mechanisms of Radix Curcumae-Flos Caryophylli moutan couple in the treatment of LF, which provides reference for further research.
查看全文   查看/发表评论  下载PDF阅读器
关闭

分享按钮